Published in Cancer Weekly, October 10th, 2000
"The aim of our experiments is to develop new therapeutical approaches for the treatment of brain tumors," stated Drs. Szilvia Desaknai and Geza Safrany from the National Research Institute for Radiobiology and Radiogygenie, Budapest, Hungary. "Glioma cells are transfected with adenovirus vectors coding for genes that sensitize cells to chemotherapeutic and antiviral agents. Such genes are the uracil phosphoribosyltransferase (UPRT) and thymidine kinase (TK) genes."
Desaknai and Safrany presented data from their study at the 14th European Immunology Meeting, held September...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.